These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8375528)

  • 1. Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea.
    Genazzani AD; Petraglia F; Volpogni C; Gastaldi M; Pianazzi F; Montanini V; Genazzani AR
    Fertil Steril; 1993 Sep; 60(3):465-70. PubMed ID: 8375528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic release of prolactin in women with weight loss-related amenorrhea.
    Genazzani AD; Petraglia F; Gastaldi M; Volpogni C; Surico N; Genazzani AR
    Gynecol Endocrinol; 1994 Jun; 8(2):95-100. PubMed ID: 7942085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea.
    Genazzani AD; Petraglia F; Volpogni C; Pianazzi F; Montanini V; D'Ambrogio G; Genazzani AR
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):607-11. PubMed ID: 8252752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile growth hormone release in normal women during the menstrual cycle.
    Faria AC; Bekenstein LW; Booth RA; Vaccaro VA; Asplin CM; Veldhuis JD; Thorner MO; Evans WS
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):591-6. PubMed ID: 1424184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects.
    Genazzani AD; Luisi M; Malavasi B; Strucchi C; Luisi S; Casarosa E; Bernardi F; Genazzani AR; Petraglia F
    Eur J Endocrinol; 2002 Mar; 146(3):347-56. PubMed ID: 11888841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss.
    Genazzani AD; Petraglia F; Fabbri G; Monzani A; Montanini V; Genazzani AR
    Fertil Steril; 1990 Aug; 54(2):222-6. PubMed ID: 2379623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea.
    Genazzani AD; Petraglia F; Gastaldi M; Volpogni C; Gamba O; Genazzani AR
    Fertil Steril; 1995 Nov; 64(5):951-6. PubMed ID: 7589640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of growth hormone pulsatility by sex steroids in female goats.
    Yonezawa T; Mogi K; Li JY; Sako R; Yamanouchi K; Nishihara M
    Endocrinology; 2005 Jun; 146(6):2736-43. PubMed ID: 15761040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH)-releasing hormone-induced GH response in hypothalamic amenorrhea: evidence of altered central neuromodulation.
    Genazzani AD; Petraglia F; Gastaldi M; Gamba O; Corazza F; D'Ambrogio G; Genazzani AR
    Fertil Steril; 1996 May; 65(5):935-8. PubMed ID: 8612852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss.
    Genazzani AD; Gamba O; Petraglia F
    J Endocrinol Invest; 1998 Jun; 21(6):353-7. PubMed ID: 9699126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human leptin in women with hypothalamic amenorrhea.
    Welt CK; Chan JL; Bullen J; Murphy R; Smith P; DePaoli AM; Karalis A; Mantzoros CS
    N Engl J Med; 2004 Sep; 351(10):987-97. PubMed ID: 15342807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea.
    Genazzani AD; Stomati M; Bersi C; Luisi S; Fedalti M; Santuz M; Esposito G; Petraglia F; Genazzani AR
    J Endocrinol Invest; 2000 Sep; 23(8):526-32. PubMed ID: 11021769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinology of gonadotropin-releasing hormone induced cycles in hypothalamic amenorrhea: the role of the pulse dose.
    Braat DD; Schoemaker J
    Fertil Steril; 1991 Dec; 56(6):1054-9. PubMed ID: 1743321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D; Montz FJ; Lobo RA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.